Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic's Genomic VP Leaves; Ciphergen Names Chief Scientific Officer; Alfa Wassermann Appoints New Officers; Others

This article has been updated to correct Mark Flocco's tenure at Bruker Daltonics.


Dennis Rossi, Gene Logic's senior vice-president and general manager for genomics, resigned for personal reasons and to pursue other career opportunities, Gene Logic said yesterday.


The company announced Rossi's departure at the same time it said its genomics revenue would miss second quarter and full year forecasts. Gene Logic said an interim leadership was "in place" but declined to identify it. The company did not comment when GenomeWeb News asked about searching for a replacement.

Eric Fung has been promoted to chief scientific officer of Ciphergen Biosystems, the company said Monday. He will also chair the newly formed Scientific Advisory Board.


Prior to his promotion, Fung was vice-president of clinical and medical affairs. He joined Ciphergen in 2000 as a lead scientist in the newly formed Biomarker Discovery Center. Prior to joining Ciphergen, Fung was a Howard Hughes sponsored researcher at Stanford University.


He completed his anatomic pathology internship at Stanford Medical School and obtained his MD and a PhD in molecular neuroscience from the Johns Hopkins University School of Medicine. He received his BS in biology from the California Institute of Technology .

Kay Napier has joined the board of directors for Third Wave Technologies, the company said on Monday. Napier is a 20-year veteran of Procter & Gamble.

Alfa Wassermann named Mark Flocco and Dino DiCamillo as vice-president and president, respectively, to its proteomic technologies division, Alfa Wassermann Proteomic Technologies, the company said last week.


DiCamillo comes to Alfa Wassermann from Invitrogen, where he was vice-president of environmental diagnostics and commercial operations. Prior to that, he was president of Dynal Biotech, spent 13 years with Applied Biosystems, and has worked for Nicolet Instruments and Bio-Rad Laboratories .


DiCamillo is a graduate of Lake Superior State University and earned an executive MBA from Temple University.


Flocco was appointed to the newly created position of vice-president of business development and marketing. He most recently served as business development manager for clinical proteomics and biomarker discovery at Bruker Daltonics before joining Alfa Wassermann. Previously, Flocco worked as the northeast regional sales manager for Ciphergen Biosystems. He worked for eight years at Beckman Coulter in sales, marketing, and technical roles, and also served as director of microchemistry at Princeton University.  


Flocco earned a BS in biology at Widener College.

HTG added two new national account managers to its sales force to meet increased demand for its ArrayPlate qNPA technology in two US regions, the company said on Tuesday.


Craig Rine and Michael Angarita will be responsible for sales and support of HTG's quantitative Nuclease Protection Assay technology in the Northeast and Midwest, respectively.


Rine joins the company after serving as drug discovery manager of Invitrogen. He also served as the director of US sales at MesoScale Discovery and director of the academic market segment at PerkinElmer Life Sciences.


He earned an MBA from Northeastern University and a BS from Western Connecticut State University.


Angarita comes to HTG from Telechem International, where he was director of sales.


Angarita earned an MBA from the Washington University School of Business and a BS from the New York Institute of Technology.

Garry Miyada joined NuGEN Technologies as vice-president of product development, the company said Wednesday.


Miyada spent the past 14 years at Affymetrix, where he held several positions, including senior director of expression product development. Prior to Affymetrix, he spent five years as a research scientist at Syva.


Miyada was a post doctoral fellow at the Beckman Research Institute of the City of Hope. He received his PhD in molecular biology from the University of California, Los Angeles and a BA in biochemistry and molecular biology from the University of California, Santa Barbara.

Harold Swerdlow has joined The Dolomite Centre, a new subsidiary of Syrris, as chief technology officer, Syrris said this week.


Previously, Swerdlow was head of technology development at Solexa and a group leader at the Center for Genomics Research of the Karolinska Institute in Stockholm, Sweden.


The Dolomite Centre is the first microfluidic application center in the world, Syrris said in a statement. A Dti grant of £2 million ($3.7 million) funded the center's launch.

Promoted? Changing jobs? GenomeWeb News wants to know. E-mail us at [email protected] to announce your move in PEOPLE, a weekly roundup of personnel changes in the genomics industry.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.